EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Role of the MUTYH Gene in Breast, Ovarian and Endometrial Cancer

Carla Lintas iD, Benedetta Canalis, Alessia Azzarà iD, Giovanna Sabarese iD, Giuseppe Perrone iD, Fiorella Gurrieri iD

Genes · 2024

DOI: 10.3390/genes15050554 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Carla Lintas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit of Medical Genetics, Department of Medicine, University Campus-Biomedico of Rome, Via Alvaro del Portillo 21, 00128 Roma, Italy. Hauptthemen laut MEDLINE: DNA Glycosylases, Endometrial Neoplasms, Ovarian Neoplasms, Breast Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ANIA Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: MUTYH germline monoallelic variants have been detected in a number of patients affected by breast/ovarian cancer or endometrial cancer, suggesting a potential susceptibility role, though their significance remains elusive since the disease mechanism is normally recessive. Hence, the aim of this research was to explore the hypothesis that a second hit could have arisen in the other allele in the tumor tissue. Methods: we used Sanger sequencing and immunohistochemistry to search for a second MUTYH variant in the tumoral DNA and to assess protein expression, respectively. Results: we detected one variant of unknown significance, one variant with conflicting interpretation of pathogenicity and three benign/likely benign variants; the MUTYH protein was not detected in the tumor tissue of half of the patients, and in others, its expression was reduced. Conclusions: our results fail to demonstrate that germinal monoallelic MUTYH variants increase cancer risk through a LOH (loss of heterozygosity) mechanism in the somatic tissue; however, the absence or partial loss of the MUTYH protein in many tumors suggests its dysregulation regardless of MUTYH genetic status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA GlycosylasesEndometrial NeoplasmsOvarian NeoplasmsBreast NeoplasmsHumansFemaleMiddle AgedLoss of HeterozygosityGenetic Predisposition to DiseaseAgedAdult

Stichwörter der Autor:innen

MUTYHautosomal dominantautosomal recessivebreast cancergerminalsecond hit

Substanzen

DNA GlycosylasesmutY adenine glycosylase

Autor:innen und Institutionen

  • Research Unit of Medical Genetics, Department of Medicine, University Campus-Biomedico of Rome, Via Alvaro del Portillo 21, 00128 Roma, Italy.
  • Operative Research Unit of Medical Genetics, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Roma, Italy.
  • Operative Research Unit of Anatomical Pathology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Roma, Italy.
  • Research Unit of Anatomical Pathology, Department of Medicine, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 21, 00128 Roma, Italy.

ORCID-Profile: Carla Lintas, Alessia Azzarà, Giovanna Sabarese, Giuseppe Perrone, Fiorella Gurrieri

Förderung

  • ANIA Foundation

Zitieren

APA

Lintas, C., Canalis, B., Azzarà, A., Sabarese, G., Perrone, G., & Gurrieri, F. (2024). Exploring the Role of the MUTYH Gene in Breast, Ovarian and Endometrial Cancer. Genes. https://doi.org/10.3390/genes15050554

Vancouver

Lintas C, Canalis B, Azzarà A, Sabarese G, Perrone G, Gurrieri F. Exploring the Role of the MUTYH Gene in Breast, Ovarian and Endometrial Cancer. Genes. 2024. doi:10.3390/genes15050554

BibTeX
@article{Lintas2024,
  author = {Lintas, Carla and Canalis, Benedetta and Azzarà, Alessia and Sabarese, Giovanna and Perrone, Giuseppe and Gurrieri, Fiorella},
  title = {Exploring the Role of the MUTYH Gene in Breast, Ovarian and Endometrial Cancer},
  journal = {Genes},
  year = {2024},
  doi = {10.3390/genes15050554}
}
Kostenlos starten →